BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 26784131)

  • 1. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes Technology: Monitoring, Analytics, and Optimal Control.
    Kovatchev B
    Cold Spring Harb Perspect Med; 2019 Jun; 9(6):. PubMed ID: 30126835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities.
    Rodbard D
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S3-S13. PubMed ID: 26784127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring.
    Kovatchev BP; Patek SD; Ortiz EA; Breton MD
    Diabetes Technol Ther; 2015 Mar; 17(3):177-86. PubMed ID: 25436913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
    Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R
    J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative Considerations for Evolving Artificial Pancreas Devices.
    Long MT; Coursin DB; Rice MJ
    Anesth Analg; 2019 May; 128(5):902-906. PubMed ID: 30198923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in development of an artificial pancreas.
    Klonoff DC; Cobelli C; Kovatchev B; Zisser HC
    J Diabetes Sci Technol; 2009 Sep; 3(5):1002-4. PubMed ID: 20144412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes Device Interoperability for Improved Diabetes Management.
    Silk AD
    J Diabetes Sci Technol; 2015 Jul; 10(1):175-7. PubMed ID: 26178738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia.
    Gómez AM; Marín Sánchez A; Muñoz OM; Colón Peña CA
    Endocrinol Nutr; 2015 Dec; 62(10):485-92. PubMed ID: 26531841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Glucose Sensor Symposium: Continuous Glucose Monitoring Systems (CGMS) for Hospitalized and Ambulatory Patients at Risk for Hyperglycemia, Hypoglycemia, and Glycemic Variability.
    Joseph JI; Torjman MC; Strasma PJ
    J Diabetes Sci Technol; 2015 Jul; 9(4):725-38. PubMed ID: 26078254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
    Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
    J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated blood glucose control in type 1 diabetes: A review of progress and challenges.
    Bertachi A; Ramkissoon CM; Bondia J; Vehí J
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):172-181. PubMed ID: 29279252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress of artificial pancreas devices towards clinical use: the first outpatient studies.
    Russell SJ
    Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):106-11. PubMed ID: 25692927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?
    Trevitt S; Simpson S; Wood A
    J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes Technology in the Inpatient Setting for Management of Hyperglycemia.
    Davis GM; Galindo RJ; Migdal AL; Umpierrez GE
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):79-93. PubMed ID: 31980123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How technology has changed diabetes management and what it has failed to achieve.
    Ratheau L; Jeandidier N; Moreau F; Sigrist S; Pinget M
    Diabetes Metab; 2011 Dec; 37 Suppl 4():S57-64. PubMed ID: 22208712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of diabetes mellitus and future directions in care.
    Chatterjee S; Davies MJ
    Postgrad Med J; 2015 Nov; 91(1081):612-21. PubMed ID: 26453594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis.
    Karageorgiou V; Papaioannou TG; Bellos I; Alexandraki K; Tentolouris N; Stefanadis C; Chrousos GP; Tousoulis D
    Metabolism; 2019 Jan; 90():20-30. PubMed ID: 30321535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.